Total Payments
$6,428
2024 Payments
$1,100
Companies
25
Transactions
315
Medicare Patients
22,702
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$6,302 (98.0%)
Education$126.22 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,302 | 311 | 98.0% |
| Education | $126.22 | 4 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,454 | 96 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,029 | 72 | $0 (2024) |
| Lilly USA, LLC | $617.42 | 17 | $0 (2022) |
| GENZYME CORPORATION | $608.97 | 22 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $425.84 | 10 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $357.28 | 7 | $0 (2021) |
| Amgen Inc. | $320.12 | 6 | $0 (2021) |
| PFIZER INC. | $293.84 | 25 | $0 (2024) |
| LEO Pharma Inc. | $220.94 | 11 | $0 (2023) |
| Genentech USA, Inc. | $177.34 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,100 | 43 | E.R. Squibb & Sons, L.L.C. ($297.72) |
| 2023 | $956.82 | 53 | Novartis Pharmaceuticals Corporation ($399.45) |
| 2022 | $1,114 | 62 | ABBVIE INC. ($436.24) |
| 2021 | $716.15 | 50 | AbbVie Inc. ($234.48) |
| 2020 | $29.54 | 2 | Novartis Pharmaceuticals Corporation ($15.85) |
| 2019 | $794.06 | 36 | Novartis Pharmaceuticals Corporation ($181.07) |
| 2018 | $931.14 | 39 | Lilly USA, LLC ($284.48) |
| 2017 | $786.01 | 30 | PFIZER INC. ($177.40) |
All Payment Transactions
315 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: Immunology | ||||||
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.46 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.88 | General |
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Immunology | ||||||
| 10/15/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.35 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $14.81 | General |
| 09/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $112.49 | General |
| Category: Immunology | ||||||
| 09/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 08/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: FACIAL AESTHETICS | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Dermatology | ||||||
| 08/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.94 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.86 | General |
| Category: Immunology | ||||||
| 07/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: IMMUNOLOGY | ||||||
| 07/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: Immunology | ||||||
| 06/27/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunology | ||||||
| 06/27/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: Immunology | ||||||
| 06/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: Immunology | ||||||
| 06/05/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Dermatology | ||||||
| 06/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $30.54 | General |
| Category: Immunology | ||||||
| 05/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: IMMUNOLOGY | ||||||
| 05/29/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 5,203 | 14,045 | $856,169 | $367,121 |
| 2022 | 27 | 5,742 | 14,404 | $972,471 | $406,973 |
| 2021 | 30 | 5,840 | 13,668 | $995,928 | $452,036 |
| 2020 | 29 | 5,917 | 11,947 | $979,372 | $419,017 |
Total Patients
22,702
Total Services
54,064
Medicare Billing
$1.6M
Procedure Codes
109
All Medicare Procedures & Services
109 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 889 | 1,303 | $318,249 | $139,317 | 43.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 1,094 | 1,303 | $126,618 | $51,070 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 551 | 683 | $90,845 | $39,430 | 43.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 1,021 | 8,561 | $80,959 | $36,207 | 44.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 671 | 790 | $65,256 | $27,661 | 42.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 172 | $32,439 | $13,579 | 41.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 158 | 175 | $28,384 | $12,373 | 43.6% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 71 | 81 | $24,335 | $11,362 | 46.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 48 | 52 | $13,509 | $6,125 | 45.3% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 40 | 41 | $10,756 | $4,748 | 44.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 77 | 77 | $12,773 | $4,712 | 36.9% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 26 | 28 | $7,692 | $3,374 | 43.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 17 | 18 | $7,898 | $3,036 | 38.4% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 68 | 68 | $7,205 | $2,523 | 35.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 29 | 30 | $4,365 | $1,932 | 44.3% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 19 | 22 | $4,014 | $1,771 | 44.1% |
| 10040 | Acne surgery | Office | 2023 | 25 | 25 | $4,185 | $1,596 | 38.1% |
| 17263 | Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | Office | 2023 | 12 | 12 | $3,366 | $1,388 | 41.2% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 43 | 50 | $4,143 | $1,254 | 30.3% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 14 | 16 | $3,155 | $1,242 | 39.4% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 12 | 12 | $2,910 | $1,130 | 38.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 86 | 112 | $2,416 | $992.06 | 41.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 126 | 414 | $696.81 | $298.37 | 42.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 998 | 1,449 | $354,347 | $148,407 | 41.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 1,117 | 1,331 | $131,104 | $52,285 | 39.9% |
About Donald Posner
Donald Posner is a Dermatology healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548243793.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Donald Posner has received a total of $6,428 in payments from pharmaceutical and medical device companies, with $1,100 received in 2024. These payments were reported across 315 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($6,302).
As a Medicare-enrolled provider, Posner has provided services to 22,702 Medicare beneficiaries, totaling 54,064 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 109 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Shreveport, LA
- Active Since 11/22/2005
- Last Updated 07/08/2007
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1548243793
Products in Payments
- TALTZ (Drug) $617.42
- SKYRIZI (Biological) $611.32
- COSENTYX (Biological) $590.40
- DUPIXENT (Biological) $487.50
- Sotyktu (Drug) $359.97
- COSENTYX (Drug) $356.81
- Humira (Biological) $343.99
- DUPIXENT DUPILUMAB INJECTION (Biological) $309.70
- EUCRISA (Drug) $261.02
- RINVOQ (Biological) $205.15
- Enbrel (Biological) $195.12
- Bimzelx (Biological) $152.47
- ADBRY (Biological) $151.15
- Zelboraf (Biological) $115.00
- OPZELURA (Drug) $110.61
- TREMFYA (Drug) $65.78
- HUMIRA (Biological) $61.25
- Otezla (Drug) $55.56
- Erivedge (Biological) $46.50
- ENSTILAR (Drug) $41.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Shreveport
Dr. Jason Romero, Md, MD
Dermatology — Payments: $6,482
Dermatology $6,482
Mr. David Clemons, Md, MD
Dermatology — Payments: $6,132
Dermatology $6,132
Steven Heard, M.d, M.D
Dermatology — Payments: $5,704
Dermatology $5,704
Mrs. Anne Bryan, Md, MD
Dermatology — Payments: $4,824
Dermatology $4,824
Dr. Laura Haynie, M.d, M.D
Dermatology — Payments: $4,607
Dermatology $4,607
David Cooksey, Md, MD
Dermatology — Payments: $551.96
Dermatology $551.96